Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2008

View Archived Issues

New role for endogenous microRNAs in cancer metastasis discovered

Readthrough AChE splice variant may be linked to Abeta pathology in AD

Avalon initiates characterization of identified compounds from collaboration with Novartis

Nventa reports positive data from second cohort of patients in phase I clinical trial of HspE7

Interim analysis recommends continuation of VITAL-1 trial of GVAX immunotherapy

Schering-Plough reports results from IDEAL study comparing leading hepatitis C therapies

Ankrd26 gene disruption gives rise to obesity and gigantism in mice

FDA sends warning letters over compounded menopause hormone therapy drugs

Novel antidiabetic agents disclosed in recent Merck Frosst patent

Recent AstraZeneca and Icos patents describe new agents for respiratory and allergic disorders

Recent patents disclose new therapeutic agents for obesity and lipoprotein disorders

Amkor's stroke drug nears end of phase I and prepares for phase II in 2008

BioCancell receives FDA approval for phase IIb bladder cancer study

Biofrontera initiates phase III BF-200 ALA trial in actinic keratosis

Pfizer submits NDA for Fablyn in osteoporosis

NDA filed for Keppra XR extended-release tablets

Alvesco gains FDA approval for asthma therapy

Glenmark's lead diabetes candidate named melogliptin

Head to head study comparing rosuvastatin and atorvastatin commences

Pozen submits human lymphocyte study for Treximet to the FDA

VGX receives FDA clearance to commence clinical trials of VGX-1027

ZymoGenetics and Merck receive FDA agreement for atacicept SPA in general SLE

Preliminary results for RVX-208 phase I study show good safety and tolerability

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.